Table 5.

Logistic Analysis of Risk Factors for 2-year Vascular Access Failure in the HD Patients Group

Risk factors	Simple model			Multiple model
	OR	95% CI	P	OR	95% CI	P
Logistic analysis with EMP
DM	1.79	0.69–4.65	0.233	1.92	0.65–5.69	0.238
HTN	1.18	0.36–3.88	0.791	1.32	0.29–5.98	0.719
Old age (>50 years)	5.31	1.13–24.98	0.035	6.86	1.21–38.84	0.029
CD31+CD42−EMP
<25%	1.00			1.00
25–50%	0.94	0.23–3.90	0.929	1.14	0.23–5.59	0.877
50–75%	1.00	0.24–4.18	1.000	1.02	0.21–4.95	0.981
>75%	2.73	0.72–10.27	0.138	5.81	1.11–23.48	0.037
CD51+EMP
<25%	1.00			1.00
25–50%	1.41	0.33–5.98	0.644	0.57	0.09–3.65	0.551
50–75%	2.50	0.60–10.34	0.206	1.25	0.25–6.33	0.785
>75%	1.88	0.45–7.82	0.388	0.74	0.14–4.09	0.731
Logistic analysis with PMP*
DM	1.79	0.69–4.65	0.233	1.55	0.56–4.32	0.472
HTN	1.18	0.36–3.88	0.791	1.71	0.44–6.65	0.437
Old age (>50 years)	5.31	1.13–24.98	0.035	6.10	1.19–31.39	0.030
CD31+CD42+PMP
<25%	1.00			1.00
25–50%	0.94	0.20–4.41	0.939	0.72	0.14–3.63	0.692
50–75%	2.67	0.65–10.97	0.174	2.06	0.47–9.12	0.341
>75%	3.00	0.74–12.11	0.123	3.00	0.68–13.16	0.145

DM, diabetes mellitus; EMP, endothelial microparticle; HTN, hypertension; PMP, platelet-derived microparticle.